Identifying the radioresponsive genome for genomics-guided radiotherapy
Authors
West, Catharine MLAffiliation
Division of Cancer Studies, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust Hospital, Manchester, M20 4BX, UK.Issue Date
2020
Metadata
Show full item recordCitation
West CML. Identifying the radioresponsive genome for genomics-guided radiotherapy. JNCI: Journal of the National Cancer Institute. 2020.Journal
Journal of the National Cancer InstituteDOI
10.1093/jnci/djaa098PubMed ID
32726420Additional Links
https://dx.doi.org/10.1093/jnci/djaa098Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/jnci/djaa098
Scopus Count
Collections
Related articles
- Interfacial properties as predictors of radioresistance in cervical cancer.
- Authors: Anand P, Huilgol N, Banerjee R
- Issue date: 2007 Oct 1
- Genomic-adjusted radiation dose to personalise radiotherapy.
- Authors: Kaidar-Person O, Poortmans P, Salgado R
- Issue date: 2021 Sep
- Radiotherapy with genomic-adjusted radiation dose.
- Authors: Musunuru HB, Keller A, Beriwal S
- Issue date: 2021 Nov
- Radiotherapy with genomic-adjusted radiation dose.
- Authors: Kashihara T, Kashihara K
- Issue date: 2021 Nov
- Radiotherapy with genomic-adjusted radiation dose - Authors' reply.
- Authors: Scott JG, Sedor G, Scarborough JA, Kattan MW, Torres-Roca JF
- Issue date: 2021 Nov